Блог – PharmCAT.NET

PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль

Найти:

Свежие записи

Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0

Галерея

Drug Shortages
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-03-24 By FDA
FDA approves first treatment for activated phosphoinositide 3-kinase delta syndrome
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
Drug Safety and Risk Management Advisory Committee Roster
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
Blood Products Advisory Committee April 26, 2023 Meeting Announcement - 04/26/2023
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-03-24 By FDA
GDUFA Implementation Quarterly Meetings between FDA and Industry
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
Over-the-Counter (OTC) Drug Review | OTC Monograph Reform in the CARES Act
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Spondylitis, Ankylosing;Arthritis, Rheumatoid;Uveitis;Colitis, Ulcerative;Psoriasis;Arthritis, Psoriatic;Crohn Disease;Hidradenitis Suppurativa;Arthritis, Date of authorisation: 24/08/2017, Revision: 20, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-03-24
Drug Compounding and Drug Shortages
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
Over-The-Counter Monograph Drug User Fee Program (OMUFA)
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
Dermatologic and Ophthalmic Drugs Advisory Committee Roster
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-24 By FDA
Methods and Approaches for Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products - 04/27/2023
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-03-23 By FDA
FDA CDER & JHU CERSI Workshop | Addressing Challenges in the Design and Analysis of Rare Disease Clinical Trials: Considerations and Tools - 05/02/2023
Source: FDA - What's New: Drugs RSS Feed Published on 2023-03-23 By FDA
Immune Globulin Hypersensitivity Reactions: Root Causes and Mitigation; Public Workshop - 03/30/2023
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-03-23 By FDA

Предыдущие записи

Тема: Scaffold от Danny Cooper.